Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for J & D Millennium, Inc
75.86
+0.67 (0.89%)
After Hours: 75.86 0.00 (0.00%)
Feb 12, 5:43PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 75.03 - 76.31
52 week 71.07 - 96.67
Open 75.65
Vol / Avg. 515,570.00/991,379.00
Mkt cap 7.06B
P/E 18.57
Div/yield     -
EPS 4.08
Shares 95.50M
Beta 0.82
Inst. own 100%
Apr 27, 2016
Q2 2016 Varian Medical Systems Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 11, 2016
Varian Medical Systems Inc Annual Shareholders Meeting
Jan 27, 2016
Q1 2016 Varian Medical Systems Inc Earnings Call
Jan 27, 2016
Q1 2016 Varian Medical Systems Inc Earnings Release
Jan 12, 2016
Varian Medical Systems Inc at JPMorgan Healthcare Conference
Nov 18, 2015
Varian Medical Systems Inc at Jefferies Global Healthcare Conference
Nov 16, 2015
Varian Medical Systems Inc at Brean Capital Life Sciences Summit Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '16) 2015
Net profit margin 11.76% 13.29%
Operating margin 15.41% 17.71%
EBITD margin - 19.03%
Return on average assets 9.75% 11.84%
Return on average equity 21.39% 24.73%
Employees 7,300 -
CDP Score - 89 C

Address

3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4245834 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer, taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, accessories, information management, treatment planning and image processing software. The Company’s customers include university research and community hospitals, private and governmental institutions, healthcare agencies, doctors’ offices and cancer care clinics.

Officers and directors

R. Andrew Eckert Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy E. Guertin Vice Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Elisha W. Finney Chief Financial Officer, Executive Vice President - Finance
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kolleen T. Kennedy Executive Vice President and President - Oncology Systems
Age: 56
Bio & Compensation  - Reuters
Clarence R. Verhoef Senior Vice President - Finance, Corporate Controller
Age: 60
Bio & Compensation  - Reuters
John W. Kuo Senior Vice President, General Counsel, Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Sunny Sanyal Senior Vice President; President - Imaging Components Businesses
Age: 51
Bio & Compensation  - Reuters
Rafael Torres Senior Vice President - Business Development and Strategy
Bio & Compensation  - Reuters
Susan L. Bostrom Independent Director
Age: 55
Bio & Compensation  - Reuters